120 related articles for article (PubMed ID: 12699468)
1. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study.
Hall JD; Bissonette EA; Boyd JC; Theodorescu D
BJU Int; 2003 May; 91(7):603-7. PubMed ID: 12699468
[TBL] [Abstract][Full Text] [Related]
2. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.
Hall JD; Boyd JC; Lippert MC; Theodorescu D
Urology; 2003 Feb; 61(2):402-7. PubMed ID: 12597956
[TBL] [Abstract][Full Text] [Related]
3. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer.
Krupski T; Petroni GR; Bissonette EA; Theodorescu D
Urology; 2000 May; 55(5):736-42. PubMed ID: 10792092
[TBL] [Abstract][Full Text] [Related]
4. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent.
Lippert MC; McClain R; Boyd JC; Theodorescu D
Cancer; 1999 Dec; 86(12):2642-8. PubMed ID: 10594859
[TBL] [Abstract][Full Text] [Related]
5. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
[TBL] [Abstract][Full Text] [Related]
6. An investigation of the health beliefs and motivations of complementary medicine clients.
Sirois FM; Gick ML
Soc Sci Med; 2002 Sep; 55(6):1025-37. PubMed ID: 12220087
[TBL] [Abstract][Full Text] [Related]
7. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
Bradley EB; Bissonette EA; Theodorescu D
BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
[TBL] [Abstract][Full Text] [Related]
8. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of the use of alternative therapies by men with localized prostate cancer.
Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
[TBL] [Abstract][Full Text] [Related]
10. Treatment decision-making strategies and influences in patients with localized prostate carcinoma.
Gwede CK; Pow-Sang J; Seigne J; Heysek R; Helal M; Shade K; Cantor A; Jacobsen PB
Cancer; 2005 Oct; 104(7):1381-90. PubMed ID: 16080181
[TBL] [Abstract][Full Text] [Related]
11. Attitudes and use of complementary medicine in men with prostate cancer.
Wilkinson S; Gomella LG; Smith JA; Brawer MK; Dawson NA; Wajsman Z; Dai L; Chodak GW
J Urol; 2002 Dec; 168(6):2505-9. PubMed ID: 12441950
[TBL] [Abstract][Full Text] [Related]
12. Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy.
Ihrig A; Keller M; Hartmann M; Debus J; Pfitzenmaier J; Hadaschik B; Hohenfellner M; Herzog W; Huber J
BJU Int; 2011 Oct; 108(8):1274-8. PubMed ID: 21410634
[TBL] [Abstract][Full Text] [Related]
13. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.
Beebe-Dimmer JL; Wood DP; Gruber SB; Douglas JA; Bonner JD; Mohai C; Zuhlke KA; Shepherd C; Cooney KA
Urology; 2004 Feb; 63(2):282-7. PubMed ID: 14972472
[TBL] [Abstract][Full Text] [Related]
14. Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy.
Fulmer BR; Bissonette EA; Petroni GR; Theodorescu D
Cancer; 2001 Jun; 91(11):2046-55. PubMed ID: 11391584
[TBL] [Abstract][Full Text] [Related]
15. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.
Boon H; Westlake K; Stewart M; Gray R; Fleshner N; Gavin A; Brown JB; Goel V
Urology; 2003 Nov; 62(5):849-53. PubMed ID: 14624907
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of complementary medicine in urologic practice. A review of recent studies with emphasis on use among prostate cancer patients.
Zimmerman RA; Thompson IM
Urol Clin North Am; 2002 Feb; 29(1):1-9, vii. PubMed ID: 12109336
[TBL] [Abstract][Full Text] [Related]
17. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis.
Nam RK; Fleshner N; Rakovitch E; Klotz L; Trachtenberg J; Choo R; Morton G; Danjoux C
J Urol; 1999 May; 161(5):1521-4. PubMed ID: 10210387
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of dietary and physical activity lifestyle modification for men following radiotherapy or radical prostatectomy for localised prostate cancer: a qualitative investigation.
Hackshaw-McGeagh LE; Sutton E; Persad R; Aning J; Bahl A; Koupparis A; Millett C; Martin RM; Lane JA
BMC Urol; 2017 Oct; 17(1):94. PubMed ID: 29017509
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
